Refine by
Infection Control Prevention Articles & Analysis
131 news found
In an epidemic, better knowledge can lead to wiser policy and can save lives. Can wastewater-based measurements of SARS-CoV-2 activity help us understand the effects of COVID-19 vaccination, and how those effects might change with new variants like Delta? To understand how wastewater can help us better understand the role of vaccines during this Delta wave, we should first look back to how we ...
“Basic facility cleaning and disinfection procedures, personal hygiene, wound care, and personal protective equipment (PPE) can all contribute greatly towards mitigating infection risks on the job and in the built environment. At CTSI, we offer infection control, industrial hygiene, and environmental testing, training, and consulting for ...
International Infection Prevention Week (IIPW) has been championed by the Association for Professionals in Infection Control and Epidemiology since 1986. The annual event highlights the importance of infection prevention professionals and their efforts and control practices. ...
The Association for Professionals in Infection Control and Epidemiology (APIC) has championed International Infection Prevention Week since 1986. For 2024, the annual event is taking place from October 13th to the 19th. International Infection Prevention Week highlights the importance of ...
Their newest production discusses International Infection Prevention Week (IIPW). “For 2024, IIPW is taking place from October 13th to the 19th,” said Paul Cochrane, President of Cochrane & Associates and the IAQ Video Network. “Infection prevention professionals and their prevention ...
“Since 2009, the MRSA Survivors Network has organized this annual campaign to raise awareness and educate the public and healthcare providers on ways to prevent and mitigate infections due to MRSA and other pathogens. It’s important to note that MRSA infections can cause serious problems inside and outside of healthcare settings. ...
In May, the Centers for Disease Control and Prevention (CDC) announced the release of new guidance for preventing the spread of infections in K-12 schools. ...
Superbugs, also known as multidrug-resistant bacteria, are a growing concern as conventional antibiotics become less effective in treating infections. The development of vaccines against superbugs is an important area of research because vaccines can help prevent infections from occurring in the first place and reduce the need for antibiotics. By ...
Introduction Intraoperative irrigation is a commonly used method aimed at reducing microbial burden by removing tissue debris, metabolic waste, and tissue exudate from the surgical field prior to site closure.1 With the absence of universally established standard of care and robust clinical data, the selection of appropriate irrigation solution remains a topic of debate. Isotonic saline has ...
The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). ...
Mucormycetes are a group of fungi that can cause a rare but serious fungal infection known as mucormycosis reports the Centers for Disease Control and Prevention (CDC). ...
Through the Vizient contract, TOMI aims to enhance infection prevention and control measures across the healthcare industry. ...
Frequently referred to as staph, it is commonly found on the skin and hair, as well as in the nose and throat of people and animals. The Centers for Disease Control and Prevention (CDC) even reports that about 30% of people carry Staphylococcus aureus in their nose. ...
As an expert in virology and microbiology, Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera. Measuring antibody titers against specific viruses is indispensable to virology and several assays have been exploited based on similar principles, i.e., serial dilutions ...
FREDERICK, Md., March 13, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the fourth quarter ended December 31, 2022, after the close of the financial markets on Thursday, March 16, 2023 and will hold a conference call at ...
FREDERICK, Md., Jan. 25, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announces that TOMI will present its SteraMist brand of products at three upcoming International Society for Pharmaceutical Engineering (ISPE) Conferences in the first quarter of 2023: The ISPE ...
FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announces that the National Health Services (NHS) Wales purchased SteraMist ionized Hydrogen Peroxide (iHP) technology further expanding presence in Great Britain. NHS Wales is a publicly funded ...
Particular support for decolonisation of pathogens which is the approach taken by its XF-73 Nasal programme Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today reports on the publication of findings from the US Food and Drug ...
Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced the receipt of a $3.6 million award from the Department of Defense (DoD) for advanced biomedical product development in support of Naval operations. The award from the Medical Technology Consortium (MTEC), a 501(c)(3) biomedical technology consortium ...
Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, is pleased to announce the commencement of an Investigational New Drug (IND) enabling safety study with its novel XF-73 Dermal formulation. This study is the second of two planned preclinical safety studies of the XF-73 ...